Similarly, based on analysis of the International Cancer Genome Consortium (ICGC) data, higher expression of NR3C1 correlated with worse survival in pancreatic cancer patients (Fig. 8i). This evidence concerns the gene NR3C1 and familial pancreatic carcinoma.